Vivasure Medical Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
42
- Latest Deal Type
-
2ndary - Private
- Investors
-
14
Vivasure Medical General Information
Description
Developer of an advanced polymer implant designed to focus on minimally invasive vessel closure. The company's implants offer a large-hole closure device that is used at the end of large-bore catheter primary interventions such as endovascular aneurysm repair and transcatheter aortic valve replacement, enabling physicians to deliver a fully absorbable implant to seal the arteriotomy site.
Contact Information
Website
www.vivasuremedical.comCorporate Office
- Parkmore Business Park West
- Galway H91 V3KP
- Ireland
Corporate Office
- Parkmore Business Park West
- Galway H91 V3KP
- Ireland
Vivasure Medical Timeline
Vivasure Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Secondary Transaction - Private | 01-Apr-2024 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series D) | 14-Mar-2023 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 22-Dec-2020 | Completed | Generating Revenue | |||
| 7. Grant | 09-Oct-2019 | Completed | Generating Revenue | |||
| 6. Debt - General | 24-Sep-2019 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 08-Sep-2016 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 30-Sep-2015 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 06-Sep-2013 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 10-Sep-2012 | $5.18M | $12.3M | Completed | Startup | |
| 1. Early Stage VC | 08-Jul-2010 | $7.12M | $7.12M | Completed | Startup |
Vivasure Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series C | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series B | ||||||||
| Series A | 11,250,226 | $0.001064 | $1.06 | $1.06 | 1x | $1.06 | 12% | |
| Series A | 638,509 | $0.001064 | $0.86 | $0.86 | 1x | $0.86 | 0.68% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Vivasure Medical Comparisons
Industry
Financing
Details
Vivasure Medical Competitors (12)
One of Vivasure Medical’s 12 competitors is Vasorum, a Private Equity-Backed company based in Dublin, Ireland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vasorum | Private Equity-Backed | Dublin, Ireland | ||||
| Vascular Graft Solutions | Private Equity-Backed | Tel Aviv, Israel | ||||
| Invibio | Corporation | United Kingdom | ||||
| Edwards Lifesciences | Corporation | Irvine, CA | ||||
| Avinger | Formerly VC-backed | Redwood City, CA |
Vivasure Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Vivasure Medical Patents
Vivasure Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240407774-A1 | Delivery system and method for vascular closure implant | Pending | 07-Jun-2023 | ||
| US-20250032107-A1 | Implant for vascular closure | Pending | 01-Nov-2021 | ||
| EP-4426204-A1 | Implant for vascular closure | Pending | 01-Nov-2021 | ||
| US-20220257225-A1 | Implantable devices, systems and methods for closing aperture | Active | 17-Feb-2021 | ||
| EP-4294282-A1 | Implantable devices, systems and methods for closing aperture | Pending | 17-Feb-2021 | A61B17/0057 |
Vivasure Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Vivasure Medical Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Abiomed | Corporation | Minority | ||
| Haemonetics | Corporation | Minority | ||
| Kinled Holding | Family Office | Minority | ||
| Orchestra BioMed | Corporation | Minority | ||
| European Innovation Council Fund | Venture Capital | Minority |
Vivasure Medical FAQs
-
When was Vivasure Medical founded?
Vivasure Medical was founded in 2009.
-
Where is Vivasure Medical headquartered?
Vivasure Medical is headquartered in Galway, Ireland.
-
What is the size of Vivasure Medical?
Vivasure Medical has 42 total employees.
-
What industry is Vivasure Medical in?
Vivasure Medical’s primary industry is Surgical Devices.
-
Is Vivasure Medical a private or public company?
Vivasure Medical is a Private company.
-
What is Vivasure Medical’s current revenue?
The current revenue for Vivasure Medical is .
-
How much funding has Vivasure Medical raised over time?
Vivasure Medical has raised $104M.
-
Who are Vivasure Medical’s investors?
Abiomed, Haemonetics, Kinled Holding, Orchestra BioMed, and European Innovation Council Fund are 5 of 14 investors who have invested in Vivasure Medical.
-
Who are Vivasure Medical’s competitors?
Vasorum, Vascular Graft Solutions, Invibio, Edwards Lifesciences, and Avinger are some of the 12 competitors of Vivasure Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
